CLL
Clinical trials for CLL explained in plain language.
Never miss a new study
Get alerted when new CLL trials appear
Sign up with your email to follow new studies for CLL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cholesterol drug shows promise in leukemia combo trial
Disease control CompletedThis early-phase study tested adding the cholesterol drug pitavastatin to the standard cancer drug venetoclax for people with chronic lymphocytic leukemia (CLL) or acute myeloid leukemia (AML). The main goal was to find a safe dose and check for side effects. Only 6 people took p…
Matched conditions: CLL
Phase: PHASE1 • Sponsor: University of California, Irvine • Aim: Disease control
Last updated May 26, 2026 05:53 UTC
-
CLL drug safety checked with common blood thinners
Disease control CompletedThis study followed 45 people with chronic lymphocytic leukemia (CLL) who were taking the targeted drug acalabrutinib (Calquence) along with a direct oral anticoagulant (DOAC) — a type of blood thinner. The goal was to see how often serious bleeding occurred. Researchers tracked …
Matched conditions: CLL
Sponsor: iOMEDICO AG • Aim: Disease control
Last updated May 26, 2026 05:45 UTC
-
New drug combo shows promise for Hard-to-Treat blood cancers
Disease control CompletedThis study tested a combination of two drugs, acalabrutinib and pembrolizumab, in 161 people with different types of blood cancers like lymphoma and leukemia. The main goal was to check safety and see how well the drugs worked together. Researchers measured side effects and tumor…
Matched conditions: CLL
Phase: PHASE1, PHASE2 • Sponsor: Acerta Pharma BV • Aim: Disease control
Last updated May 22, 2026 13:53 UTC